United States US: Specialist Surgical Workforce: per 100,000 population data was reported at 54.710 Number in 2015. This records a decrease from the previous number of 64.560 Number for 2011. United States US: Specialist Surgical Workforce: per 100,000 population data is updated yearly, averaging 59.635 Number from Dec 2011 (Median) to 2015, with 2 observations. The data reached an all-time high of 64.560 Number in 2011 and a record low of 54.710 Number in 2015. United States US: Specialist Surgical Workforce: per 100,000 population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Specialist surgical workforce is the number of specialist surgical, anaesthetic, and obstetric (SAO) providers who are working in each country per 100,000 population.; ; The Lancet Commission on Global Surgery (www.lancetglobalsurgery.org).; Weighted Average;

About this Dataset

Carefully curated list of “Surgeon / Doctor / Dentist” in USA. We strive to keep our customers satisfied, so they no longer have to worry about finding quality leads. Which is why we offer a 100% data guarantee. If there is any information missing or incorrect we will replace it for you. Contact us immediately. What you will find below: - Contact Name - Company - Email - Contact no. & more

Category

Health & Medicine

Keywords

USA Surgeon,USA Doctors,US Surgeons,US Doctors,US Dentist

Row Count

8768

Price

$4999.00

About this Dataset

Carefully curated list of “Surgeon / Doctor / Dentist” in New Jersey. We strive to keep our customers satisfied, so they no longer have to worry about finding quality leads. Which is why we offer a 100% data guarantee. If there is any information missing or incorrect we will replace it for you. Contact us immediately. What you will find below: - Contact Name - Company - Email - Contact no. & more

Category

Health & Medicine

Keywords

New Jersey Surgeon,New Jersey Doctors,New Jersey Dentist,US Surgeons,US Doctor

Row Count

1662

Price

$299.00

The Pediatric Participant Use Data File (PUF) is a Health Insurance Portability and Accountability Act (HIPAA)-compliant data file containing cases submitted to the American College of Surgeons National Surgical Quality Improvement Program Pediatric® (ACS NSQIP Pediatric®). The PUF contains patient-level, aggregate data and does not identify hospitals, health care providers, or patients. The ACS NSQIP Pediatric collects data on approximately 120 variables, including preoperative risk factors, intraoperative variables, and 30-day postoperative mortality and morbidity outcomes for patients undergoing major surgical procedures in both the inpatient and outpatient setting. The intended purpose of this file is to provide researchers at participating sites with a data resource they can use to investigate and advance the quality of care delivered to the surgical patient through the analysis of cases captured by ACS NSQIP Pediatric. Additional procedure-specific PUFs are available for appendectomy, spinal fusion, and cerebrospinal fluid shunt.

ABSTRACT Introduction: There is a lack of information about cardiac surgery training and professional practice in Latin American (LATAM) countries. This study is the first comparative analysis of cardiac surgical training and professional practice across LATAM and provides the fundamentals for future academic projects of the Latin American Association of Cardiac and Endovascular Surgery (LACES). Methods: International survey-based comparative analysis of the training and professional practice of cardiac surgeons across LATAM. Trainees (residents/fellows) and staf (graduated) surgeons from LATAM countries were included. Results: A total of 289 respondents (staf surgeons N=221 [76.5%]; residents/fellows N=68 [23.5%]) from 18 different countries participated in the survey. Most surgeons (N=92 [45.3%]) reported being unsatisfied with their salaries. Most respondents (N=181 [62.6%]) stated that it was difficult to obtain a leadership position, and 149 (73.8%) stated that it was difficult to find a job after completing training. Only half of the trainee respondents (N=32 [47.1%]) reported that their program had all resident spots occupied. Only 22.1% (N=15) of residents/fellows were satisfied with their training programs. The majority (N=205 [70.9%]) of respondents would choose cardiac surgery as their specialty again. Most surgeons (N=129 [63.9%]) and residents/fellows (N=52 [76.5%]) indicated that the establishment of a LATAM cardiac surgery board examination would be beneficial. Conclusion: Modernization and standardization of training, as well as greater access to opportunities, may be required in LATAM to increase professional satisfaction of cardiac surgeons and to reduce disparities in the specialty. Such changes may enhance the regional response to the dynamic challenges in the feld.

Snapshot img

Atrial Fibrillation Surgery Market Size 2024-2028

The atrial fibrillation surgery market size is forecast to increase by USD 1.99 billion at a CAGR of 14.76% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of cardiovascular disorders, particularly rhythm disturbances such as atrial fibrillation. This condition can lead to acute cardiac events, including shock and acute respiratory distress, making effective treatment a priority. Surgical procedures, including catheter ablation, have emerged as viable options for managing atrial fibrillation. However, the high cost of ablation catheters and the need for specialized expertise and facilities pose challenges to widespread adoption. Additionally, advances in technology, such as digital catheterization labs in hospitals, are driving competition and improving patient outcomes. Despite these advancements, the market remains competitive, with ongoing research and development efforts aimed at reducing treatment costs and improving patient care.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

Atrial fibrillation (AF), a common heart rhythm disorder, affects millions of people worldwide. According to the American Heart Association, AF accounts for over 2.7 million cases in the US alone. This condition, characterized by irregular and often rapid heartbeats, increases the risk of stroke, heart failure, and other complications. The AF surgery market encompasses various procedures aimed at restoring normal heart rhythm. These procedures include catheter ablation and surgical ablation. Catheter ablation involves using a catheter to deliver energy to the heart to destroy small areas of heart tissue that cause irregular heartbeats.

In addition, surgical ablation, on the other hand, is an open-heart procedure where surgeons use heat or cold energy to remove the affected heart tissue. Regulatory policies and data requirements play a crucial role in the AF surgery market. The US Food and Drug Administration (FDA) regulates the approval and use of medical devices and procedures related to AF surgery. These regulatory requirements ensure the safety and efficacy of AF surgery procedures. The cost of AF surgery is a significant factor influencing the market. The cost of catheter ablation and surgical ablation varies depending on the specific procedure, hospital location, and patient's insurance coverage.

Additionally, continuous data collection and analysis can help improve treatment outcomes and reduce healthcare costs. The AF surgery market faces regulatory issues related to skilled labor and reimbursement policies. The shortage of skilled labor, particularly in rural areas, can limit access to AF surgery procedures. Reimbursement policies also play a role in the market, as some insurers may not cover the full cost of AF surgery procedures, making them less accessible to some patients. In conclusion, the AF surgery market is driven by the increasing prevalence of AF and the need for effective treatment options. Regulatory policies and data requirements ensure the safety and efficacy of AF surgery procedures, while advanced technologies such as remote patient monitoring and continuous data analysis are transforming the market. The cost of AF surgery and the availability of skilled labor remain significant challenges for the market.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Catheter ablation
  Surgical ablation


Geography

  North America

    US


  Europe

    Germany
    UK


  Asia

    China
    Japan


  Rest of World (ROW)

By Product Insights

The catheter ablation segment is estimated to witness significant growth during the forecast period. Atrial fibrillation, a type of cardiac arrhythmia, is characterized by an irregular and often rapid heart rhythm. This condition, which affects the electrical systems regulating the heart, can lead to symptoms such as chest pain, shortness of breath, fatigue, dizziness, and fainting. The prevalence of atrial fibrillation is increasing, driven in part by the aging population and the rising incidence of cardiovascular disorders, including myocarditis, rhythm disturbances, acute cardiac shock, and acute respiratory distress. The growing number of cases and the resulting demand for effective treatments have fueled the growth of the market. One of the most common treatments for this condition is catheter ablation, a non-surgical procedure that uses heat or cold to scar the heart tissue responsible for the abnormal rhythm.

In addition, the market for catheter ablation equipment and services is expected to continue growing at a significant rate d

Does receiving a medical education outside the United States impact a surgeon’s performance? We study this question by matching operations performed by internationally-trained surgeons to those performed by US-trained surgeons in reanalysis of a large health outcomes study. An effective matched design must achieve several goals, including balancing covariate distributions marginally, ensuring units within individual pairs have similar values on key covariates, and using a sufficiently large sample from the raw data. Yet in our study, optimizing some of these goals forces less desirable results on others. We address such tradeoffs from a multi-objective optimization perspective by creating matched designs that are Pareto optimal with respect to two goals. We provide general tools for generating representative subsets of Pareto optimal solution sets and articulate how they can be used to improve decision-making in observational study design. In the motivating surgical outcomes study, formulating a multi-objective version of the problem helps us balance an important variable without sacrificing two other design goals, average closeness of matched pairs on a multivariate distance and size of the final matched sample. Keywords: matching; Pareto optimality; fine balance; network flow optimization; multi-objective optimization.

Snapshot img

Intraoperative Neuromonitoring Market Size 2024-2028

The intraoperative neuromonitoring market size is forecast to increase by USD 1.47 billion, at a CAGR of 8.51% between 2023 and 2028. The market is experiencing significant growth due to the increasing number of surgical procedures performed, particularly in the geriatric population and those with cardiovascular conditions. IONM technology plays a crucial role in ensuring accurate neuromonitoring during surgeries, leading to improved patient outcomes and reduced complications. This technology is increasingly being adopted in various surgical procedures, including those related to neurology, orthopedics, and cardiovascular conditions. One trend driving market growth is the emergence of portable IONM systems, which offer greater flexibility and convenience for healthcare providers. However, the high cost of devices and services remains a challenge for market growth. For instance, Alzheimer's disease, a condition prevalent in the geriatric population, requires specialized IONM during related surgeries, further increasing the cost. Medtronic and Accurate Neuromonitoring are key players in the market, offering advanced IONM solutions to meet the growing demand. To stay competitive, market players are focusing on developing cost-effective solutions while maintaining the highest standards of accuracy and reliability. In summary, the IONM market is witnessing growth due to the increasing volume of surgeries, particularly in the geriatric population and those with cardiovascular conditions.

Market Analysis

Request Free Sample

The intraoperative neuromonitoring (IONM) market is witnessing significant advancements, driven by the increasing adoption of technology in healthcare and the growing demand for real-time patient monitoring during surgeries. IONM is a critical component of neurosurgery that ensures the preservation of neurological function during surgical procedures. Connected services and cloud-based solutions are revolutionizing the IONM landscape. With the integration of core cloud technologies, IONM data can be accessed and analyzed in real-time, enabling surgeons to make informed decisions during surgeries. This not only enhances patient safety but also streamlines enterprise operations and industrial processes.

Moreover, the importance of information sharing and offloaded computation in the market cannot be overstated. Teleoperation and MEC (Multi-access Edge Computing) technologies facilitate seamless data exchange between healthcare providers and specialists, ensuring optimal care delivery. Moreover, offloading computation to the cloud reduces the need for expensive on-premises hardware and allows for cost-effective service execution. The technology giants are investing heavily in AI-based systems to improve the accuracy and efficiency of IONM. These systems leverage advanced algorithms to analyze patient data and provide real-time insights, enabling surgeons to make data-driven decisions during surgeries. Furthermore, robots are increasingly being used in IONM applications, offering benefits such as precision, consistency, and reduced human error.

Also, the IONM market is witnessing growth across various industry verticals, including consumer services and industrial processes. In consumer services, IONM is being used to monitor patients undergoing minimally invasive surgeries and to ensure optimal outcomes. In industrial processes, IONM is being employed to enhance the safety and efficiency of manufacturing operations. In conclusion, the market is experiencing steady growth, driven by advancements in cloud technologies, AI, and robotics. The integration of these technologies is enabling real-time data analysis, improved patient outcomes, and cost savings for healthcare providers. As the demand for advanced surgical procedures continues to rise, the importance of IONM in ensuring patient safety and optimizing operational efficiency will only grow.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Insourced IONM
  Outsourced IONM


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France


  Asia



  Rest of World (ROW)

By Type Insights

The insourced ionm segment is estimated to witness significant growth during the forecast period. Intraoperative neuromonitoring (IONM) is a valuable technology utilized during various surgical procedures, including spinal surgery, neurosurgery, vascular surgery, ENT surgery, and orthopedic surgery. This technology plays a crucial role in minimizing post-operative injuries by monitoring the nervous system in real-time. The global IONM market is experiencing significant growth due to severa

Snapshot img

Surgical Robots Market Size 2025-2029

The surgical robots market size is forecast to increase by USD 18.08 billion at a CAGR of 28.5% between 2024 and 2029.

The market is witnessing significant growth due to the rising adoption of these advanced systems to enhance the precision of surgical procedures. This trend is particularly noticeable in developed regions, where the focus on minimally invasive surgeries and improved patient outcomes is driving demand. Accuray Inc., a leading company, offers surgical robots such as the Cyberknife S7 system.
However, the high cost and affordability remain a challenge, limiting their adoption in developing countries. HD cameras integrated into surgical robotic systems enable surgeons to perform complex procedures with minimal invasiveness, benefiting patients with chronic diseases such as bone degenerative diseases, arthritis, and osteoporosis, as well as those undergoing hip replacement surgeries, knee replacement surgeries, and joint repairs. the adoption of surgical robotic systems is not limited to inpatient facilities but also extends to ambulatory surgical centers and healthcare facilities. 

What will be the Size of the Surgical Robots Market During the Forecast Period?

Request Free Sample

The market is experiencing significant growth due to the increasing adoption of robotic technology in various surgical procedures. HD cameras integrated provide enhanced visualization, enabling more precise and accurate surgeries. Outpatient surgery and ambulatory surgery centers are increasingly utilizing surgical robots to offer minimally invasive procedures, reducing hospital stays and recovery time. Medicare and other health insurance providers are recognizing the benefits of robotic surgery, leading to increased reimbursements. Surgical errors are minimized through the use of automated instruments, making procedures safer for patients. Robotic technology is being applied to bone degenerative diseases such as arthritis, osteoporosis, and joint-related surgeries like hip and knee replacements.
Moreover, chronic diseases like cardiac conditions, cancer, and cataracts are also being treated with surgical intervention using robotic systems. Instruments and accessories for soft tissues and bones are continually advancing, expanding the scope of robotic surgery applications. Physicians and surgeons are embracing this technology to improve patient outcomes and reduce complications.

How is this Surgical Robots Industry segmented and which is the largest segment?

The surgical robots industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Application

  General and laparoscopy surgery
  Gynecological surgery
  Orthopedic surgery
  Neurosurgery
  Urology and others


End-user

  Hospitals
  Ambulatory service centers


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France


  Asia

    China
    India
    Japan


  Rest of World (ROW)

By Application Insights

The general and laparoscopy surgery segment is estimated to witness significant growth during the forecast period.

Surgical robots have significantly transformed minimally invasive surgeries, including laparoscopic procedures, by offering surgeons enhanced precision and visualization. The global surgical procedures market is projected to grow due to the increasing number of surgeries performed annually, with an estimated 200-400 million procedures worldwide in 2023 (World Health Organization). Surgical robots have become increasingly popular due to their benefits, such as quicker patient recovery, shorter hospital stays, health insurance and reduced post-operative complications. In the United States, outpatient surgeries, including urological, sterilization, gynaecological, and general surgeries, have seen significant growth in ambulatory surgery centers and clinics.

Get a glance at the Surgical Robots Industry report of share of various segments Request Free Sample

The General and laparoscopy surgery segment was valued at USD 1.33 billion in 2019 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 39% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

Surgical robots have gained significant traction In the healthcare industry due to their precision, dexterity, smaller incisions, and faster recovery times. Chronic diseases, such as cardiovascular diseases and respiratory disorders, affect a large population In the US, with

BackgroundFrailty is frequently used by clinicians to help determine surgical outcomes. The frailty index, which represents the frequency of frailty indicators present in an individual, is one method for evaluating patient frailty to predict surgical outcomes. However, the frailty index treats all indicators of frailty that are used in the index as equivalent. Our hypothesis is that frailty indicators may be divided into groups of high and low-impact indicators and this separation will improve surgical discharge outcome prediction accuracy.Data and methodsPopulation data for inpatient elective operations was collected from the 2018 American College of Surgeons National Surgical Quality Improvement Program Participant Use Files. Artificial neural network (ANN) models trained using backpropagation are used to evaluate the relative accuracy for predicting surgical outcome of discharge destination using a traditional modified frailty index (mFI) or a new joint mFI that separates high-impact and low-impact indicators into distinct groups as input variables. Predictions are made across nine possible discharge destinations. A leave-one-out method is used to indicate the relative contribution of high and low-impact variables.ResultsExcept for the surgical specialty of cardiac surgery, the ANN model using distinct high and low-impact mFI indexes uniformly outperformed the ANN models using a single traditional mFI. Prediction accuracy improved from 3.4% to 28.1%. The leave-one-out experiment shows that except for the case of otolaryngology operations, the high-impact index indicators provided more support when determining surgical discharge destination outcomes.ConclusionFrailty indicators are not uniformly similar and should be treated differently in clinical outcome prediction systems.